AC
INO icon

AXQ Capital’s Inovio Pharmaceuticals INO Stock Holding History

AXQ Capital’s Portfolio INO Stock Details INO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.2K Buy
+13,863
New +$16.4K ﹤0.01% 958

Other funds holding INO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $11.7B AUM 87.29% 1-Year Est. Return
PCIA
Prime Capital Investment Advisors Overland Park, Kansas $10.3B AUM 25.54% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
SI
Stephens Inc Little Rock, Arkansas $8.93B AUM 25.13% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return
MFA
Mayflower Financial Advisors Boston, Massachusetts $1.16B AUM 24.36% 1-Year Est. Return
SEIA
Signature Estate & Investment Advisors Los Angeles, California $5.56B AUM 26.66% 1-Year Est. Return

AXQ Capital's INO Position: Q2 2026 in Review

AXQ Capital opened a new position in Inovio Pharmaceuticals (INO) in Q2 2026: 13,863 shares worth $15.2K. The stake represents ﹤0.01% of the portfolio and ranks #958 among its holdings.

41 funds tracked by Wall St. Rank hold INO as of Q2 2026.

  • AXQ Capital held 13,863 shares of Inovio Pharmaceuticals worth $15.2K as of Q2 2026.
  • Inovio Pharmaceuticals was a new AXQ Capital position in Q2 2026.
  • Inovio Pharmaceuticals made up ﹤0.01% of AXQ Capital's portfolio in Q2 2026, its #958 holding.
  • 41 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q2 2026.

Based on AXQ Capital's 13F filing for Q2 2026, filed 6 Aug 2026.